AI Article Synopsis
- A nationwide investigation in China found the overall carriage proportion of H. influenzae among healthy populations to be 0.17, with significant variation across different provinces.
- The study analyzed data from 42 research articles involving 17,388 participants and reported that the carriage proportion was similar in children (0.17) and adults (0.14), showing no significant differences based on age, sex, or season.
- The prevalence of the encapsulated type of H. influenzae (Hib) was low at 0.01, while the non-typeable H. influenzae (NTHi) had a higher carriage proportion of 0.22.
Article Abstract
Background: A nationwide investigation on the carriage proportion of H. influenzae among healthy populations is lacking in China. The purpose of the study was to review the prevalence of pharyngeal carriage of H. influenzae among healthy populations in China, and explore its influencing factors. The serotypes distribution of H. influenzae was also analyzed.
Methods: A systematic search was conducted with key words "Haemophilus influenzae", "Carriage", and "China" or "Chinese" from inception to March 2018. After careful screening, the data of included articles were extracted with a pre-designed excel form. Then, the pooled carriage proportion of H. influenzae was calculated using the random effect model.
Results: A total of 42 studies with 17,388 participants were included. The overall pooled carriage proportion of H. influenzae was 0.17 (95% CI: 0.13-0.21), and the carriage proportion largely varied by province. Subgroup analysis indicated that the pooled carriage proportion was 0.17 (0.13-0.21) for children, and 0.14 (0.7-0.23) for adults. There were no statistically significant heterogeneity between subgroups by age (p = 0.65), sex (p = 0.88), and season (p = 0.10). The pooled carriage proportion of Hib was 0.01 (0-0.02), while the carriage proportion of NTHi was 0.22 (0.13-0.31).
Conclusion: In China, the carriage proportion of H. influenzae among healthy population was low, but it largely varied by provinces.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588945 | PMC |
| http://dx.doi.org/10.1186/s12879-019-4195-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Asymptomatic Plasmodium falciparum infections and determinants of carriage in a seasonal malaria chemoprevention setting in Northern Cameroon and south Senegal (Kedougou).
Malar J
December 2024
MARCAD Programme, The Biotechnology Centre, University of Yaoundé 1, Yaoundé, Cameroon.
Background: Among the several strategies recommended for the fight against malaria, seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine combination (SPAQ) targets children 3 months to 5 years in Sahel regions of Africa to reduce mortality and mortality. Since SMC with SPAQ is administered to symptoms-free children for prevention of malaria, it is anticipated that a proportion of asymptomatic parasitaemic children will also be treated and may result in a drop in both the overall population prevalence of asymptomatic malaria infections, subsequent risk of symptomatic malaria infections and transmission. Age-specific carriage of asymptomatic Plasmodium spp.
View Article and Find Full Text PDFThe increasing burden of group B from 2013 to 2023: a retrospective cohort study in Beijing, China.
Microbiol Spectr
December 2024
Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Group B (GBS) is a leading pathogen responsible for fatal infections in newborns primarily due to vertical transmission from colonized mothers. Cases of invasive GBS infections in adults have also increased and attracted attention recently. To comprehensively understand the evolving burden of vaginal GBS carriage in pregnant and non-pregnant women, as well as the trends in invasive GBS diseases and antibiotic resistance in China, we conducted a retrospective study using data from a large tertiary hospital in Beijing from 2013 to 2023.
View Article and Find Full Text PDFCharacterizing carrying plasmid-mediated AmpC β-lactamases to optimize detection in a diagnostic laboratory setting.
Microbiol Spectr
November 2024
Microbiology and Infectious Diseases, SA Pathology, Adelaide, South Australia, Australia.
Plasmid-mediated AmpC β-lactamases are a cause of acquired cephalosporin resistance in Gram-negative bacteria. However, consensus regarding the optimal detection method is yet to be achieved and varies depending on local epidemiology and laboratory capacity. We determined the acquired genotypic resistance mechanisms of 250 isolates with a positive AmpC screen, defined as cefoxitin MIC ≥ 8 mg/L and a positive AmpC double- disc diffusion test, using in-house designed high-resolution melt PCR, detecting plasmid-acquired genes from the CIT and DHA families.
View Article and Find Full Text PDFFaecal carriage of extended-spectrum beta-lactamase and carbapenemase-producing enterobacterales among HIV patients at Jimma Medical Center, Southwest Ethiopia.
BMC Microbiol
November 2024
School of Medical Laboratory Sciences, Institute of Health Sciences, Jimma University, Jimma, Ethiopia.
Article Synopsis
- The study examined the prevalence of extended-spectrum β-lactamase (ESBL) and carbapenemase-producing Enterobacterales (CPE) in HIV-infected patients at Jimma Medical Center, analyzing 344 stool samples for antibiotic-resistant bacteria.
- A total of 376 Enterobacterales were isolated, revealing that 13.3% were ESBL producers and 4.3% were CPE, with Klebsiella pneumoniae and E. coli being the most common resistant strains.
- Key risk factors for ESBL and CPE presence included prior use of cephalosporins, low CD4 counts, and comorbidities, highlighting the need for improved infection control and antibiotic management.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!